Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Raltegravir Potassium Salt

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 729Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    11/10/2024 Divis Laboratories
    India
    		 Korea MSD Co., Ltd. Su90-20-ND Raltegravir Potassium 2017-05-18 Divi\'s Laboratories Limited@(Undifferentiated Process) MSD International GmbH(Singapore Branch) India Unit-2, Chippada(V) Annavaram(Post), Bheemunipatnam(M) Visakhapatnam District-531 162 Andhra Pradesh, India@50 Tuas West Drive Singapore 638408
    11/10/2024 Divis Laboratories
    India
    		 Korea MSD Co., Ltd. No. 906-10-ND Raltegravir Potassium 2010-02-26 Divi\'\'s Laboratories Limited India Unit-2, Chippada Village Annavaram Post, Bheemunipatram Mandal, Visakhapatnam District Andhra Pradesh, 531162